Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Unaudited)

v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 451.2 $ 353.1
Receivables, net of allowance for doubtful accounts 106.0 91.9
Inventories 494.6 511.7
Prepaid expenses and other current assets 200.3 188.0
Total current assets 1,252.1 1,144.7
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization 429.3 447.7
Operating lease right-of-use assets 169.0 168.3
Marketing-related intangibles and other intangible assets, net 314.6 315.1
Goodwill 99.1 100.5
Deferred income tax assets 463.7 464.3
Other assets 147.4 145.3
Total assets 2,875.2 2,785.9
Current liabilities:    
Accounts payable 88.1 99.8
Member compensation liabilities 361.1 402.4
Current portion of long-term debt 9.2 20.9
Other current liabilities 563.7 489.8
Total current liabilities 1,022.1 1,012.9
Long-term debt, net of current portion 1,981.9 1,971.7
Non-current operating lease liabilities 155.2 155.7
Other non-current liabilities 150.2 155.0
Total liabilities 3,309.4 3,295.3
Commitments and contingencies
Shareholders' deficit:    
Common shares, $0.0005 par value; 2.0 billion shares authorized;103.4 million (2026) and 103.3 million (2025) shares outstanding 0.1 0.1
Paid-in capital in excess of par value 334.0 316.0
Accumulated other comprehensive loss (257.8) (251.5)
Accumulated deficit (517.8) (579.7)
Total Herbalife shareholders' deficit (441.5) (515.1)
Noncontrolling interest 7.3 5.7
Total shareholders' deficit (434.2) (509.4)
Total liabilities and shareholders' deficit $ 2,875.2 $ 2,785.9